Suspecting abuse-resistant Oxycontin, buyer kills dealer

In a drug deal gone bad in Boston, the buyer concluded that his source was selling the newer Oxycontin, reformulated to prevent abuse. It wouldn't burn, so it couldn't be smoked. Police suspect that the test failure cost the drug dealer his life. They also suspect that pills were not the reformulated Oxycontin, but rather a fake or a different drug. Article

 

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.